World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00016909
Date of registration: 17/12/2019
Prospective Registration: No
Primary sponsor: NCM-Lab, ETH Zürich
Public title: Investigation of the effects of cognitive states on sensory gating and motor output
Scientific title: Investigation of the effects of cognitive states on sensory gating and motor output
Date of first enrolment: 01/09/2018
Target sample size: 750
Recruitment status: Recruiting
URL:  http://drks.de/search/en/trial/DRKS00016909
Study type:  observational
Study design:  Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: basic science  
Phase: 
Countries of recruitment
Switzerland
Contacts
Name: Nicole    Wenderoth
Address:  August-Piccard-Hof 1 8093 Zürich Switzerland
Telephone: +41 44 635 61 55
Email: nicole.wenderoth@hest.ethz.ch
Affiliation:  NCM-Lab, ETH Zürich
Name: Nicole    Wenderoth
Address:  Auguste-Piccard-Hof 1 8093 Zürich Switzerland
Telephone: +41 44 635 61 55
Email: nicole.wenderoth@hest.ethz.ch
Affiliation:  NCM-Lab, ETH Zürich
Key inclusion & exclusion criteria
Inclusion criteria: Healthy participants
Age 18 – 65 years
Normal physical and mental health
Normal or corrected to normal vision

Exclusion criteria: Known history of neurological, musculoskeletal or neuromuscular disorders.
Pregnancy.
Participants with metal implants in their body including pacemakers, or electronically/magnetically/mechanically activated implants.


Age minimum: 18 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Basic research in healthy participants Healthy participants
Intervention(s)
Group 1: The project involves neurophysiological measurements (e.g. fMRI, EEG and EMG) as well as non-invasive brain stimulation (e.g. TMS, tCS) during behavioural tests (e.g. sensorimotor and cognitive tasks).
Primary Outcome(s)
Electrophysiological markers of brain activity as measured with EEG (Electroencephalography).
BOLD (blood oxygenation level dependent) signal changes as measured with fMRI (Functional magnetic resonance imaging).
Muscle activity as measured with EMG (Electromyography).
Performance on behavioural tasks (accuracy, reaction time, and others).
Eye and motion tracking measures. The planned end date of the study is 1. September 2024.
Secondary Outcome(s)
Not applicable
Secondary ID(s)
Source(s) of Monetary Support
NCM-Lab, ETH Zürich
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 23/08/2018
Contact:
Kantonale Ethikkommission Zürich [Kantonale Ethikkommission Zürich ]
Results
Results available:
Date Posted:
Date Completed:
URL: http://drks.de/search/en/trial/DRKS00016909#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history